Presentation New Drug-eluting Stent Designs: Are Improved Clinical Outcomes Possible? Presenter: Gregg W. Stone March 06, 2012 REGISTER for free or LOG IN to view this content DES/BRS/DCB Presentation Up Next Presentation Estudio MR-IMPACT II: IRM de Perfusión Cardíaca frente a SPECT para Detección de EAC Presenter: J. Schwitter March 06, 2012 More slides + Presentation MR-IMPACT II: Perfusion-Cardiac MR vs. SPECT for the Detection of CAD Presenter: Juerg Schwitter March 06, 2012 Presentation Meta-Analysis of RCTs on Effect of Cilostazol on Restenosis and Outcomes After PCI Presenter: S. Friedland March 06, 2012 We Recommend
Presentation Estudio MR-IMPACT II: IRM de Perfusión Cardíaca frente a SPECT para Detección de EAC Presenter: J. Schwitter March 06, 2012
Presentation MR-IMPACT II: Perfusion-Cardiac MR vs. SPECT for the Detection of CAD Presenter: Juerg Schwitter March 06, 2012
Presentation Meta-Analysis of RCTs on Effect of Cilostazol on Restenosis and Outcomes After PCI Presenter: S. Friedland March 06, 2012